Amylyx Pharmaceuticals Inc Cash Flow Quality Index
Amylyx Pharmaceuticals Inc cash flow quality index. Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Quality Index of 2.86x as of December 2023. Operating cash flow of $13.55 Million exceeds net income of $4.73 Million, indicating high earnings quality where cash backs reported profits. See Amylyx Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Amylyx Pharmaceuticals Inc (2023–2023)
Cash flow quality index of Amylyx Pharmaceuticals Inc from 2023 to 2023. Historical Cash Flow Quality Index for Amylyx Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Amylyx Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Amylyx Pharmaceuticals Inc Cash Flow Quality Index by Year (2023–2023)
Amylyx Pharmaceuticals Inc cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Amylyx Pharmaceuticals Inc. For the full cash flow conversion analysis, see AMLX cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.24x | $11.92 Million | $49.27 Million | — |